246. Methylmalonic acidemia Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 23 / Drugs : 31 - (DrugBank : 8) / Drug target genes : 17 - Drug target pathways : 23
Methylmalonic acidemia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
246 | Methylmalonic acidemia | - |
236 | Pseudohypoparathyroidism | 15.812 |
63 | Idiopathic thrombocytopenic purpura | 15.393 |
226 | Interstitial cystitis with Hunners ulcer | 15.294 |
299 | Cystic fibrosis | 15.216 |
265 | Lipodystrophy | 5.068 |
78 | Hypopituitarism | 4.535 |
21 | Mitochondrial disease | 4.486 |
97 | Ulcerative colitis | 4.002 |
96 | Crohn disease | 3.966 |
2 | Amyotrophic lateral sclerosis | 3.962 |
46 | Malignant rheumatoid arthritis | 3.948 |
6 | Parkinson disease | 3.945 |
13 | Multiple sclerosis/Neuromyelitis optica | 3.892 |
162 | Pemphigoid | 1.312 |
56 | Behcet disease | 1.281 |
271 | Ankylosing spondylitis | 1.240 |
50 | Dermatomyositis | 1.196 |
107 | Juvenile idiopathic arthritis | 1.176 |
84 | Sarcoidosis | 1.090 |
8 | Huntington disease | 1.087 |
245 | Propionic acidemia | 1.000 |